157 related articles for article (PubMed ID: 37910256)
21. Expression of far upstream element-binding protein 1 correlates with c-Myc expression in sacral chordomas and is associated with tumor progression and poor prognosis.
Wen H; Ma H; Li P; Zheng J; Yu Y; Lv G
Biochem Biophys Res Commun; 2017 Sep; 491(4):1047-1054. PubMed ID: 28780352
[TBL] [Abstract][Full Text] [Related]
22. [A preliminary study of serum marker alpha-enolase in the diagnosis of hepatocellular carcinoma].
Luo X; Wei YQ; Hai L; Hu YC; Zhao ZJ; Ma WL; Ma LN; Liu XY; Ding XC
Zhonghua Gan Zang Bing Za Zhi; 2019 Jul; 27(7):505-510. PubMed ID: 31357775
[No Abstract] [Full Text] [Related]
23. Upregulation of far upstream element-binding protein 1 (FUBP1) promotes tumor proliferation and unfavorable prognosis in tongue squamous cell carcinoma.
Chen Y; Liu J; Geng N; Feng C
Int J Biol Markers; 2020 Jun; 35(2):56-65. PubMed ID: 32339054
[TBL] [Abstract][Full Text] [Related]
24. PROX1 and β-catenin are prognostic markers in pancreatic ductal adenocarcinoma.
Saukkonen K; Hagström J; Mustonen H; Juuti A; Nordling S; Kallio P; Alitalo K; Seppänen H; Haglund C
BMC Cancer; 2016 Jul; 16():472. PubMed ID: 27411302
[TBL] [Abstract][Full Text] [Related]
25. In pancreatic cancer, chemotherapy increases antitumor responses to tumor-associated antigens and potentiates DNA vaccination.
Mandili G; Curcio C; Bulfamante S; Follia L; Ferrero G; Mazza E; Principe M; Cordero F; Satolli MA; Spadi R; Evangelista A; Giordano D; Viet D; Cappello P; Novelli F
J Immunother Cancer; 2020 Oct; 8(2):. PubMed ID: 33115943
[TBL] [Abstract][Full Text] [Related]
26. Plasma autoantibodies against heat shock protein 70, enolase 1 and ribonuclease/angiogenin inhibitor 1 as potential biomarkers for cholangiocarcinoma.
Rucksaken R; Pairojkul C; Pinlaor P; Khuntikeo N; Roytrakul S; Selmi C; Pinlaor S
PLoS One; 2014; 9(7):e103259. PubMed ID: 25058392
[TBL] [Abstract][Full Text] [Related]
27. Over-Expression of Alpha-Enolase as a Prognostic Biomarker in Patients with Pancreatic Cancer.
Sun L; Guo C; Cao J; Burnett J; Yang Z; Ran Y; Sun D
Int J Med Sci; 2017; 14(7):655-661. PubMed ID: 28824297
[No Abstract] [Full Text] [Related]
28. Enolase 1, a Moonlighting Protein, as a Potential Target for Cancer Treatment.
Qiao G; Wu A; Chen X; Tian Y; Lin X
Int J Biol Sci; 2021; 17(14):3981-3992. PubMed ID: 34671213
[TBL] [Abstract][Full Text] [Related]
29. ENO1 promotes immunosuppression and tumor growth in pancreatic cancer.
Huang CK; Lv L; Chen H; Sun Y; Ping Y
Clin Transl Oncol; 2023 Jul; 25(7):2250-2264. PubMed ID: 36820953
[TBL] [Abstract][Full Text] [Related]
30. Expression of Alpha-Enolase (ENO1), Myc Promoter-Binding Protein-1 (MBP-1) and Matrix Metalloproteinases (MMP-2 and MMP-9) Reflect the Nature and Aggressiveness of Breast Tumors.
Cancemi P; Buttacavoli M; Roz E; Feo S
Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31416219
[TBL] [Abstract][Full Text] [Related]
31. Enolase1 overexpression regulates the growth of gastric cancer cells and predicts poor survival.
Qiao H; Wang Y; Zhu B; Jiang L; Yuan W; Zhou Y; Guan Q
J Cell Biochem; 2019 Nov; 120(11):18714-18723. PubMed ID: 31218757
[TBL] [Abstract][Full Text] [Related]
32. Association between anti-Porphyromonas gingivalis or anti-α-enolase antibody and severity of periodontitis or rheumatoid arthritis (RA) disease activity in RA.
Lee JY; Choi IA; Kim JH; Kim KH; Lee EY; Lee EB; Lee YM; Song YW
BMC Musculoskelet Disord; 2015 Aug; 16():190. PubMed ID: 26265263
[TBL] [Abstract][Full Text] [Related]
33. ENO1-targeted superparamagnetic iron oxide nanoparticles for detecting pancreatic cancer by magnetic resonance imaging.
Wang L; Yin H; Bi R; Gao G; Li K; Liu HL
J Cell Mol Med; 2020 May; 24(10):5751-5757. PubMed ID: 32285549
[TBL] [Abstract][Full Text] [Related]
34. Estrogen promotes prostate cancer cell migration via paracrine release of ENO1 from stromal cells.
Yu L; Shi J; Cheng S; Zhu Y; Zhao X; Yang K; Du X; Klocker H; Yang X; Zhang J
Mol Endocrinol; 2012 Sep; 26(9):1521-30. PubMed ID: 22734040
[TBL] [Abstract][Full Text] [Related]
35. Alpha-enolase in viral target cells suppresses the human immunodeficiency virus type 1 integration.
Kishimoto N; Yamamoto K; Iga N; Kirihara C; Abe T; Takamune N; Misumi S
Retrovirology; 2020 Sep; 17(1):31. PubMed ID: 32917235
[TBL] [Abstract][Full Text] [Related]
36. The potential significance of alpha-enolase (ENO1) in lung adenocarcinomas - A utility of the immunohistochemical expression in pathologic diagnosis.
Okudela K; Mitsui H; Matsumura M; Arai H; Shino K; Sekine A; Woo T; Suzuki T; Ishikawa Y; Umeda S; Tajiri M; Masuda M; Ohashi K
Pathol Int; 2017 Dec; 67(12):602-609. PubMed ID: 29090499
[TBL] [Abstract][Full Text] [Related]
37. A Predictive Role of Autoantibodies Against the Epitope aa168-183 of ENO1 in the Occurrence of Miscarriage Related to Thyroid Autoimmunity.
He X; Liu Y; Wang H; Sun W; Lu Y; Shan Z; Teng W; Li J
Front Immunol; 2022; 13():890502. PubMed ID: 35707546
[TBL] [Abstract][Full Text] [Related]
38. Upregulation of α enolase (ENO1) crotonylation in colorectal cancer and its promoting effect on cancer cell metastasis.
Hou JY; Cao J; Gao LJ; Zhang FP; Shen J; Zhou L; Shi JY; Feng YL; Yan Z; Wang DP; Cao JM
Biochem Biophys Res Commun; 2021 Nov; 578():77-83. PubMed ID: 34547627
[TBL] [Abstract][Full Text] [Related]
39. Diagnostic value of α-enolase expression and serum α-enolase autoantibody levels in lung cancer.
Zhang L; Wang H; Dong X
J Bras Pneumol; 2018; 44(1):18-23. PubMed ID: 29538538
[TBL] [Abstract][Full Text] [Related]
40. DLC-1 is a candidate biomarker methylated and down-regulated in pancreatic ductal adenocarcinoma.
Xue YZ; Wu TL; Wu YM; Sheng YY; Wei ZQ; Lu YF; Yu LH; Li JP; Li ZS
Tumour Biol; 2013 Oct; 34(5):2857-61. PubMed ID: 23681804
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
